1. Home
  2. FEMY vs ZDAI Comparison

FEMY vs ZDAI Comparison

Compare FEMY & ZDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Femasys Inc.

FEMY

Femasys Inc.

N/A

Current Price

$1.40

Market Cap

11.5M

Sector

Health Care

ML Signal

N/A

ZDAI

Primega Group Holdings Limited Ordinary Shares

N/A

Current Price

$1.15

Market Cap

9.6M

ML Signal

N/A

Company Overview

Basic Information
Metric
FEMY
ZDAI
Founded
2004
2022
Country
United States
Hong Kong
Employees
54
N/A
Industry
Medical/Dental Instruments
General Bldg Contractors - Nonresidential Bldgs
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
11.5M
9.6M
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
FEMY
ZDAI
Price
$1.40
$1.15
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $14.33
N/A
AVG Volume (30 Days)
★ 103.5K
5.1K
Earning Date
11-13-2026
08-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 44.71
N/A
EPS
N/A
★ N/A
Revenue
★ $2,293,313.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$328.45
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 40.77
N/A
52 Week Low
$0.29
$0.20
52 Week High
$6.29
$11.48

Technical Indicators

Market Signals
Indicator
FEMY
ZDAI
Relative Strength Index (RSI) 28.99 35.81
Support Level $0.37 $0.34
Resistance Level $3.21 $1.77
Average True Range (ATR) 0.17 0.11
MACD -0.00 -0.00
Stochastic Oscillator 17.65 4.55

Price Performance

Historical Comparison
FEMY
ZDAI

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About ZDAI Primega Group Holdings Limited Ordinary Shares

DirectBooking Technology Co Ltd, formerly Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.

Share on Social Networks: